학술논문
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Document Type
Report
Author
Fellstrom, Bengt C.; Holdaas, Hallvard; Jardine, Alan G.; Schmieder, Roland E.; Bannister, Kym; Beutler, Jaap; Chae, Dong-Wan; Cobbe, Stuart M.; Gronhagen-Riska, Carola; De Lima, Jose J.; Lins, Robert; Chevaile, Alejandro; Mayer, Gert; Parving, Hans-Henrik; Remuzzi, Giuseppe; Samuelsson, Ola; McMahon, Alan W.; Sonkodi, Sandor; Tsakiris, Dimitrios; Tesar, Vladimir; Todorov, Vasil; Suleymanlar, Gultekin; Wiecek, Andrzej; Gottlow, Mattis; Johnsson, Eva; Zannad, Faiez; Wuthrich, Rudolf P.
Source
The New England Journal of Medicine. April 2, 2009, Vol. 360 Issue 14, p1395, 13 p.
Subject
Language
English
ISSN
0028-4793
Abstract
The study aims to evaluate the efficacy of the use of statins like rosuvastatin in reducing cardiovascular events in patients undergoing hemodialysis. The results indicate that rosuvastatin did reduce the LDL cholesterol level among such patients but did not help prevent mortality from cardiovascular causes.